Overview

Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

Status:
Completed
Trial end date:
2017-07-03
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, vehicle-controlled, double-blind Phase 2 study in adults and adolescent subjects with mild to moderate atopic dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Dermavant Sciences GmbH
Dermavant Sciences, Inc.